Corteva, Inc. (NYSE: CTVA) reported financial results for the fourth quarter and full year ended December 31, 2025, highlighting growth across regions and continued demand for its seed and crop protection portfolios.
AgZen bags a $10M Series A funding round, led by DCVC Bio alongside Material Impact, which had previously led the company’s $3.5M seed round
Key Takeaways: Profluent Bio and Corteva announce a strategic collaboration in AI-based protein and genome design Partnership integrates Profluent’s generative biology models with Corteva’s Catalyst and Genlytix™ platforms Focused on […]
To provide the best experience, we use technologies like cookies to store and access device information.
